Doctorglasses Chain Co.,Ltd. (SHE:300622)
China · Delayed Price · Currency is CNY 14.35
-0.38 (-2.58%)
Aug 24, 2026, 3:04 PM CST
Doctorglasses Chain Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,387 | 1,360 | 1,203 | 1,176 | 962.24 | 887.47 |
Revenue Growth | 12.52% | 13.10% | 2.29% | 22.20% | 8.43% | 35.22% |
Gross Profit Gross Profit Growth | 829.42 | 813.87 | 732.44 | 733.69 | 588.34 | 573.63 |
Operating Income Operating Income Growth | 186.08 | 175.66 | 132.86 | 158.38 | 87.28 | 116.28 |
Net Income Net Income Growth | 158.33 | 148.61 | 103.63 | 128.06 | 75.81 | 94.78 |
Earnings Per Share EPS Growth | 0.49 | 0.46 | 0.33 | 0.41 | 0.24 | 0.30 |
EPS Growth | 42.91% | 41.30% | -19.18% | 68.16% | -19.99% | 34.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 973.84 | 582.31 | 327.48 | 258.63 | 286.3 | 285.68 |
Total Debt Total Debt Growth | 518.33 | 185.15 | 259.05 | 164.33 | 174.99 | 204.51 |
Net Cash (Debt) Net Cash Growth | 455.51 | 397.16 | 68.43 | 94.3 | 111.31 | 81.17 |
Net Cash Growth | 152.72% | 480.39% | -27.43% | -15.29% | 37.14% | -79.38% |
Net Cash Per Share Net Cash Per Share Growth | 1.42 | 1.24 | 0.22 | 0.30 | 0.36 | 0.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 291.21 | 296.96 | 275.51 | 280.94 | 208.41 | 214.33 |
Capital Expenditures CapEx Growth | -21.29 | -20.67 | -25.98 | -21.59 | -26.29 | -43.5 |
Free Cash Flow Free Cash Flow Growth | 269.92 | 276.29 | 249.53 | 259.34 | 182.13 | 170.83 |
Free Cash Flow Growth | -5.96% | 10.72% | -3.78% | 42.40% | 6.62% | 123.57% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 59.78% | 59.83% | 60.89% | 62.40% | 61.14% | 64.64% |
Operating Margin | 13.41% | 12.91% | 11.05% | 13.47% | 9.07% | 13.10% |
Pretax Margin | 14.76% | 14.11% | 10.73% | 13.96% | 9.65% | 13.66% |
Profit Margin | 11.41% | 10.92% | 8.62% | 10.89% | 7.88% | 10.68% |
FCF Margin | 19.45% | 20.31% | 20.75% | 22.05% | 18.93% | 19.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.929 | 1.929 | 0.148 | 0.330 | 0.165 | 0.275 |
Dividend Per Share Growth | 0% | 1199.60% | -54.99% | 100.06% | -40.01% | 42.85% |
Dividend Yield | 13.59% | 8.79% | 0.55% | 3.24% | 1.57% | 2.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 29.10 | 47.62 | 84.24 | 26.55 | 46.52 | 41.34 |
Forward PE | - | 51.44 | 61.30 | 22.84 | 35.19 | 29.10 |
P/FCF Ratio | 16.96 | 25.62 | 34.99 | 13.11 | 19.36 | 22.94 |
PS Ratio | 3.30 | 5.20 | 7.26 | 2.89 | 3.67 | 4.42 |